Jane Street
CORV

Jane Street’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Jane Street’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-10,622
Closed -$40K – 5993
2018
Q2 		$40K Buy
+10,622
New +$27.7K ﹤0.01% 4832
2014
Q3 		– Sell
-12,652
Closed -$99K – 3274
2014
Q2 		$99K Buy
+12,652
New +$95.6K ﹤0.01% 2360

Other funds holding CORV

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.23B AUM 51.32% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jane Street's CORV Position: Q3 2018 in Review

Jane Street sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q3 2018, closing a stake of 10,622 shares — an estimated $40K sold.

Jane Street first reported a position in CORV in Q2 2014 and held it in 2 quarters. The position peaked at $99K in Q2 2014. 36 funds tracked by Wall St. Rank hold CORV as of Q3 2018.

  • Jane Street reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q3 2018 after selling out during the quarter.
  • Jane Street sold 10,622 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q3 2018, an estimated $40K.
  • Jane Street first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q2 2014 and held it in 2 quarters.
  • Jane Street's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $99K in Q2 2014.
  • 36 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q3 2018.

Based on Jane Street's 13F filing for Q3 2018, filed 14 Nov 2018.